These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 23767761)
1. Adaptive mechanisms of Campylobacter jejuni to erythromycin treatment. Xia Q; Muraoka WT; Shen Z; Sahin O; Wang H; Wu Z; Liu P; Zhang Q BMC Microbiol; 2013 Jun; 13():133. PubMed ID: 23767761 [TBL] [Abstract][Full Text] [Related]
2. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Caldwell DB; Wang Y; Lin J Antimicrob Agents Chemother; 2008 Nov; 52(11):3947-54. PubMed ID: 18779354 [TBL] [Abstract][Full Text] [Related]
3. Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni. Hao H; Yuan Z; Shen Z; Han J; Sahin O; Liu P; Zhang Q Antimicrob Agents Chemother; 2013 Mar; 57(3):1369-78. PubMed ID: 23274667 [TBL] [Abstract][Full Text] [Related]
4. Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Lin J; Yan M; Sahin O; Pereira S; Chang YJ; Zhang Q Antimicrob Agents Chemother; 2007 May; 51(5):1678-86. PubMed ID: 17353243 [TBL] [Abstract][Full Text] [Related]
5. Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host. Luangtongkum T; Shen Z; Seng VW; Sahin O; Jeon B; Liu P; Zhang Q Antimicrob Agents Chemother; 2012 Mar; 56(3):1300-8. PubMed ID: 22183170 [TBL] [Abstract][Full Text] [Related]
6. A seventeen-year observation of the antimicrobial susceptibility of clinical Campylobacter jejuni and the molecular mechanisms of erythromycin-resistant isolates in Beijing, China. Zhou J; Zhang M; Yang W; Fang Y; Wang G; Hou F Int J Infect Dis; 2016 Jan; 42():28-33. PubMed ID: 26594011 [TBL] [Abstract][Full Text] [Related]
7. Impact of erythromycin resistance on the virulence properties and fitness of Campylobacter jejuni. Almofti YA; Dai M; Sun Y; Haihong H; Yuan Z Microb Pathog; 2011 Jun; 50(6):336-42. PubMed ID: 21377522 [TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance modulation and modes of action of (-)-α-pinene in Campylobacter jejuni. Kovač J; Šimunović K; Wu Z; Klančnik A; Bucar F; Zhang Q; Možina SS PLoS One; 2015; 10(4):e0122871. PubMed ID: 25830640 [TBL] [Abstract][Full Text] [Related]
9. Genetic diversity and antimicrobial resistance profiles of Campylobacter coli and Campylobacter jejuni isolated from broiler chicken in farms and at time of slaughter in central Italy. Pergola S; Franciosini MP; Comitini F; Ciani M; De Luca S; Bellucci S; Menchetti L; Casagrande Proietti P J Appl Microbiol; 2017 May; 122(5):1348-1356. PubMed ID: 28194914 [TBL] [Abstract][Full Text] [Related]
10. Formation of the Resistance of Campylobacter jejuni to Macrolide Antibiotics. Efimochkina NR; Stetsenko VV; Sheveleva SA Bull Exp Biol Med; 2020 Jul; 169(3):351-356. PubMed ID: 32748135 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Resistance of Human Otto SJG; Levett PN; Reid-Smith RJ; Pearl DL; Daku D; Nagle E; Horsman GB; McEwen SA Foodborne Pathog Dis; 2020 Mar; 17(3):178-186. PubMed ID: 31661323 [TBL] [Abstract][Full Text] [Related]
12. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Gibreel A; Kos VN; Keelan M; Trieber CA; Levesque S; Michaud S; Taylor DE Antimicrob Agents Chemother; 2005 Jul; 49(7):2753-9. PubMed ID: 15980346 [TBL] [Abstract][Full Text] [Related]
13. Roles of lipooligosaccharide and capsular polysaccharide in antimicrobial resistance and natural transformation of Campylobacter jejuni. Jeon B; Muraoka W; Scupham A; Zhang Q J Antimicrob Chemother; 2009 Mar; 63(3):462-8. PubMed ID: 19147521 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey. Kayman T; Abay S; Aydin F; Şahin O J Med Microbiol; 2019 Feb; 68(2):136-142. PubMed ID: 30540246 [TBL] [Abstract][Full Text] [Related]
15. Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter. Jeon B; Zhang Q J Antimicrob Chemother; 2009 May; 63(5):946-8. PubMed ID: 19279049 [TBL] [Abstract][Full Text] [Related]
16. [Molecular analysis of fluoroquinolones and macrolides resistance in Campylobacter jejuni isolates from humans, bovine and chicken meat]. González-Hein G; Cordero N; García P; Figueroa G Rev Chilena Infectol; 2013 Apr; 30(2):135-9. PubMed ID: 23677151 [TBL] [Abstract][Full Text] [Related]
17. The Current State of Macrolide Resistance in Campylobacter spp.: Trends and Impacts of Resistance Mechanisms. Bolinger H; Kathariou S Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411226 [No Abstract] [Full Text] [Related]
18. Resistance to bile salts and sodium deoxycholate in macrolide- and fluoroquinolone-susceptible and resistant Campylobacter jejuni and Campylobacter coli strains. Mavri A; Smole Možina S Microb Drug Resist; 2013 Jun; 19(3):168-74. PubMed ID: 23289436 [TBL] [Abstract][Full Text] [Related]
19. [Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method]. Žemličková H; Jakubů V; Marejková M; Urbášková P Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):184-90. PubMed ID: 25412481 [TBL] [Abstract][Full Text] [Related]
20. Contribution of CmeG to antibiotic and oxidative stress resistance in Campylobacter jejuni. Jeon B; Wang Y; Hao H; Barton YW; Zhang Q J Antimicrob Chemother; 2011 Jan; 66(1):79-85. PubMed ID: 21081547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]